title: Entecavir and intermittent etanercept therapy in a patient with concurrent hepatitis B virus infection and psoriasis.
authors.forename: Graziella
authors.initials: G
authors.lastname: Babino
authors.forename: Maria
authors.initials: M
authors.lastname: Esposito
authors.forename: Annamaria
authors.initials: A
authors.lastname: Mazzotta
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
authors.forename: Alessandro
authors.initials: A
authors.lastname: Giunta
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D000068800:Etanercept; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D011565:Psoriasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; C413685:entecavir; D006147:Guanine; D000068800:Etanercept